ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1263

Relevance and Utility of Patient Reported Outcomes Measurement Information System (PROMIS®) Instruments in SLE: A Qualitative Study

Shanthini Kasturi1, Madeline Epsten2, Adena Batterman3, Roberta Horton3, Juliette Kleinman3, Jillian Rose3, Jackie Szymonifka2, Laura Robbins4 and Lisa A. Mandl1, 1Rheumatology, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, 2Rheumatology, Hospital for Special Surgery, New York, NY, 3Social Work Programs, Hospital for Special Surgery, New York, NY, 4Education & Academic Affairs, Hospital for Special Surgery, New York, NY

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: patient outcomes, PROMIS, qualitative, Quality of life and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Title: Patient Outcomes, Preferences, and Attitudes Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: The measurement of patient reported outcomes is a priority for patient-centered high value care. This is particularly true in chronic systemic diseases such as SLE, which can have a significant ongoing impact on quality of life. PROMIS instruments are precise, reliable, and valid measures of physical, mental, and social health, but their relevance and potential value in the clinical care of SLE patients has not been explored. The aims of this study were to evaluate SLE patient perspectives on the relevance and potential utility of PROMIS computerized adaptive tests (CATs) and PROMIS10.

Methods: Adult outpatients meeting 1997 ACR SLE classification criteria were recruited from an SLE Center of Excellence. Subjects completed 12 PROMIS CATs, the PROMIS10, and participated in focus groups (women) or structured interviews (men). Focus groups and interviews explored the relevance of PROMIS domains, the potential value of PROMIS instruments in routine medical care, and identified missing domains. Transcripts were analyzed for recurring themes and concepts using grounded theory.

Results: Twenty eight women and 4 men with SLE participated in 4 focus groups and structured interviews (table 1). Participants reported that PROMIS instruments, especially CATs, reflected their experience with lupus, with women prioritizing domains of fatigue, pain interference, physical function, sleep disturbance, and cognitive abilities as most relevant, and men selecting fatigue, sleep disturbance, anxiety, pain interference, and pain behavior. Subjects identified body image, intimate relationships, pregnancy, and relationships with providers as important areas not addressed by PROMIS. Participants were enthusiastic about using PROMIS in their medical care, citing utility in validating their experience, tracking symptoms and disease progression, facilitating communication with providers, and guiding treatment plans. A recurring theme in the focus groups and interviews was the importance of doctors reviewing the survey results.

Conclusion: SLE patients endorse PROMIS instruments as relevant, valuable, and potentially useful in improving clinical care. These data identify domains of importance to SLE patients, including men’s greater emphasis on mental health, and areas where there is a need to develop PROMIS instruments. Further longitudinal studies are essential to explore how to most effectively integrate PROMIS measures in routine clinical care.

Table 1. Socio-Demographic Characteristics of Participants (n=32)

Characteristic

Value

Age, median (IQR) years

39 (33, 53.5)

Disease duration, median (IQR) years

11.6 (6.4, 24.2)

Female

28 (87.5%)

Race

White

6 (21.4%)

Black or African American

14 (50.0%)

Asian

3 (10.7%)

Other

5 (17.9%)

Ethnicity, Hispanic

9 (28.1%)

Insurance Type

Medicaid

18 (56.3%)

Medicare

5 (15.6%)

Third party/private

9 (28.1%)

Education

Some high school or less

1 (3.1%)

High school graduate

2 (6.3%)

Some college

12 (37.5%)

College graduate

10 (31.3%)

Advanced degree

7 (21.9%)

Employment (Full or Part Time)

10 (31.3%)

On Disability

18 (58.1%)


Disclosure: S. Kasturi, None; M. Epsten, None; A. Batterman, None; R. Horton, None; J. Kleinman, None; J. Rose, None; J. Szymonifka, None; L. Robbins, None; L. A. Mandl, Boehringer Ingelheim, 2,American College of Physicians, 3,Up To Date, 7.

To cite this abstract in AMA style:

Kasturi S, Epsten M, Batterman A, Horton R, Kleinman J, Rose J, Szymonifka J, Robbins L, Mandl LA. Relevance and Utility of Patient Reported Outcomes Measurement Information System (PROMIS®) Instruments in SLE: A Qualitative Study [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/relevance-and-utility-of-patient-reported-outcomes-measurement-information-system-promis-instruments-in-sle-a-qualitative-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/relevance-and-utility-of-patient-reported-outcomes-measurement-information-system-promis-instruments-in-sle-a-qualitative-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology